Related Experiment Video
Updated: Jun 8, 2026

06:34
Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice
Published on: June 2, 2023
[Perfusion brain SPECT and Alzheimer disease]
Karim Farid1, Lisette Volpe-Gillot, Nadine Caillat-Vigneron
1AP-HP, hôpital Hôtel-Dieu, service de médecine nucléaire, 75004 Paris, France. karim.farid@htd.aphp.fr
Summary
Brain SPECT imaging can detect reduced cerebral blood flow in Alzheimer's disease (AD) and predict conversion from mild cognitive impairment (MCI) to AD. This technique aids in early diagnosis and differential diagnosis of dementias.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Alzheimer's disease (AD) is the leading cause of degenerative dementia, with an identifiable asymptomatic phase.
- Cerebral blood flow (CBF) assessment is crucial for understanding neurodegenerative processes.
- Mild cognitive impairment (MCI) patients may have a high risk of converting to AD.
Purpose of the Study:
- To investigate the utility of brain single photon computed tomography (SPECT) in assessing cerebral blood flow in Alzheimer's disease.
- To evaluate the potential of brain SPECT for the early detection of MCI patients at high risk of conversion to AD.
- To explore the role of scintigraphic patterns in the differential diagnosis of neurodegenerative dementias.
Main Methods:
- Utilized brain single photon computed tomography (SPECT) to measure cerebral blood flow.
- Analyzed patterns of hypoperfusion in specific brain regions, including the medial temporal, associative posterior parietal cortex, and frontal cortex.
- Assessed MCI patients for hypoperfusion in the associative parietal cortex as a predictor of AD conversion.
Main Results:
- Alzheimer's disease is characterized by significant hypoperfusion in the medial temporal, associative posterior parietal cortex, and frontal cortex.
- Hypoperfusion in the associative parietal cortex of MCI patients is predictive of rapid conversion to Alzheimer's disease.
- Distinct scintigraphic patterns observed in brain SPECT can aid in differentiating various neurodegenerative dementias.
Conclusions:
- Brain SPECT is a valuable tool for investigating cerebral blood flow and diagnosing Alzheimer's disease.
- SPECT imaging can identify MCI patients at high risk for progression to AD, enabling early intervention.
- Neuroimaging patterns via SPECT contribute to the differential diagnosis of dementia subtypes.
Related Concept Videos
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
